Actively Recruiting
Multidimensional Prediction Model Development for Early-Onset Juvenile Idiopathic Arthritis Course and Outcomes
Led by Istituto Giannina Gaslini · Updated on 2026-10-20
130
Participants Needed
2
Research Sites
22 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective-retrospective, observational study involving at least 100 children diagnosed with early-onset Juvenile Idiopathic Arthritis JIA and 30 children with Iridocyclitis not related to JIA as a control group. The study aims to develop a multidimensional prediction model for the disease course and outcomes in early-onset JIA by monitoring patients over a 24-month period with evaluations at diagnosis and five follow-up time points. Participants with early-onset JIA will be assessed through standardized clinical disease activity scores, ultrasound exams of specific joints, detailed eye exams including slit lamp and optical coherence tomography, and collection of biological samples such as blood, urine, tears, and joint fluid when applicable. These samples will be analyzed for routine lab markers, genetic factors via whole exome sequencing, multiomic profiling, immunological characterization, and extracellular vesicle analysis. The control group with Iridocyclitis will be evaluated at diagnosis for comparison. During the 24 months, participants will undergo evaluations at baseline and months 3, 6, 12, 18, and 24 to monitor disease progression and outcomes. Researchers will use these data to build an integrated prediction model and evaluate factors linked to disease extension and eye inflammation. This study involves multiple assessments, including clinical scores, imaging, laboratory tests, and advanced molecular analyses, under the coordination of the Istituto Giannina Gaslini and collaborating centers.
CONDITIONS
Brief Title
Development of a Multidimensional Prediction Model for the Course and Outcome of Early-Onset Juvenile Idiopathic Arthritis (JIA)
Research Team
A
Alessandro Consolaro, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here